Author

Rūta Prakapaitė

University of BaselORCID 0000-0002-5741-8622Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander SchmidtiD· 1 shared Alexia FerrandiD· 1 shared Antonia Müller· 1 shared Carlos FloresiD· 1 shared Christoph DehioiD· 1 shared Cinzia FinoiD· 1 shared David BikardiD· 1 shared Kausthubh RamachandraniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Alexander SchmidtORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A bacterial nucleolus for cold adaptation

Michelle Jennifer Gut, Kerstin Dörner, Sebastian Abegg, Nusrat S. Qureshi, Kausthubh Ramachandran, Alexia Ferrand, Alexander Schmidt, Rūta Prakapaitė, Tom A. Williams, Olivier Duss, Maria Hondele

The paper identifies a nucleolus-like condensate in E. coli that forms during cold adaptation to enhance ribosome biogenesis.

bioRxiv · Sep 18, 2026 · PreprintCell Biology

Genome-scale CRISPRi profiling reveals metabolic vulnerabilities of uropathogenic Escherichia coli in human urine

Monica Ortelli, Rūta Prakapaitė, Antonia Müller, Solange Miele, Cinzia Fino, Steffi Klimke, Sarah Tschudin‐Sutter, Urs Jenal, Carlos Flores, David Bikard, Christoph Dehio

This study uses CRISPRi to identify metabolic vulnerabilities of UPEC in urine, highlighting ALS II as a druggable target.

bioRxiv · Oct 31, 2025 · PreprintMicrobiology